Compare VTR & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTR | IDXX |
|---|---|---|
| Founded | 1983 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.0B | 43.6B |
| IPO Year | 2005 | 1996 |
| Metric | VTR | IDXX |
|---|---|---|
| Price | $82.13 | $562.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $87.62 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 3.6M | 564.7K |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | ★ 184.21 | 22.59 |
| EPS | 0.11 | ★ 3.47 |
| Revenue | ★ $5,833,980,000.00 | $4,303,702,000.00 |
| Revenue This Year | $14.00 | $10.88 |
| Revenue Next Year | $8.35 | $8.59 |
| P/E Ratio | $716.36 | ★ $162.76 |
| Revenue Growth | ★ 18.47 | 10.42 |
| 52 Week Low | $61.76 | $507.55 |
| 52 Week High | $91.06 | $769.98 |
| Indicator | VTR | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 41.36 | 51.06 |
| Support Level | $79.53 | $550.28 |
| Resistance Level | $87.10 | $589.82 |
| Average True Range (ATR) | 2.16 | 15.41 |
| MACD | -0.95 | 2.25 |
| Stochastic Oscillator | 37.27 | 64.65 |
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.